nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—obesity	0.436	0.596	CbGaD
Fludrocortisone—NR3C1—obesity	0.296	0.404	CbGaD
Fludrocortisone—Diabetic—Orlistat—obesity	0.00343	0.0265	CcSEcCtD
Fludrocortisone—NR3C2—hindbrain—obesity	0.00325	0.106	CbGeAlD
Fludrocortisone—Intraocular pressure increased—Sibutramine—obesity	0.00252	0.0195	CcSEcCtD
Fludrocortisone—Impaired healing—Bupropion—obesity	0.00224	0.0173	CcSEcCtD
Fludrocortisone—Intraocular pressure increased—Bupropion—obesity	0.0022	0.017	CcSEcCtD
Fludrocortisone—Menstruation irregular—Orlistat—obesity	0.00207	0.016	CcSEcCtD
Fludrocortisone—Osteoporosis—Sibutramine—obesity	0.00198	0.0153	CcSEcCtD
Fludrocortisone—Ecchymosis—Diethylpropion—obesity	0.00197	0.0152	CcSEcCtD
Fludrocortisone—Multiple fractures—Orlistat—obesity	0.00197	0.0152	CcSEcCtD
Fludrocortisone—Fracture—Orlistat—obesity	0.00197	0.0152	CcSEcCtD
Fludrocortisone—Diabetic—Topiramate—obesity	0.00185	0.0143	CcSEcCtD
Fludrocortisone—Menstruation irregular—Bupropion—obesity	0.00175	0.0135	CcSEcCtD
Fludrocortisone—NR3C1—hindbrain—obesity	0.00175	0.0568	CbGeAlD
Fludrocortisone—Osteoporosis—Bupropion—obesity	0.00172	0.0133	CcSEcCtD
Fludrocortisone—NR3C2—adrenal cortex—obesity	0.00167	0.0543	CbGeAlD
Fludrocortisone—Hirsutism—Bupropion—obesity	0.00166	0.0129	CcSEcCtD
Fludrocortisone—Myopathy—Sibutramine—obesity	0.00158	0.0122	CcSEcCtD
Fludrocortisone—NR3C2—cardiovascular system—obesity	0.00152	0.0495	CbGeAlD
Fludrocortisone—Glaucoma—Sibutramine—obesity	0.00147	0.0114	CcSEcCtD
Fludrocortisone—Intraocular pressure increased—Topiramate—obesity	0.0014	0.0108	CcSEcCtD
Fludrocortisone—Petechiae—Sibutramine—obesity	0.00135	0.0104	CcSEcCtD
Fludrocortisone—NR3C2—pituitary gland—obesity	0.00135	0.0439	CbGeAlD
Fludrocortisone—NR3C2—adipose tissue—obesity	0.00134	0.0437	CbGeAlD
Fludrocortisone—Sweating increased—Diethylpropion—obesity	0.00133	0.0103	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Bupropion—obesity	0.00131	0.0101	CcSEcCtD
Fludrocortisone—Amenorrhoea—Orlistat—obesity	0.0013	0.0101	CcSEcCtD
Fludrocortisone—Pancreatitis—Cimetidine—obesity	0.00128	0.00987	CcSEcCtD
Fludrocortisone—Contusion—Sibutramine—obesity	0.00127	0.00983	CcSEcCtD
Fludrocortisone—NR3C2—digestive system—obesity	0.00126	0.0411	CbGeAlD
Fludrocortisone—Amenorrhoea—Sibutramine—obesity	0.00126	0.00976	CcSEcCtD
Fludrocortisone—AR—adrenal cortex—obesity	0.00124	0.0402	CbGeAlD
Fludrocortisone—NR3C2—adrenal gland—obesity	0.0012	0.0392	CbGeAlD
Fludrocortisone—Glycosuria—Bupropion—obesity	0.00119	0.00923	CcSEcCtD
Fludrocortisone—Hypernatraemia—Topiramate—obesity	0.00117	0.00906	CcSEcCtD
Fludrocortisone—Cataract—Sibutramine—obesity	0.00117	0.00901	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Benzphetamine—obesity	0.00116	0.00897	CcSEcCtD
Fludrocortisone—NR3C1—islet of Langerhans—obesity	0.00113	0.0367	CbGeAlD
Fludrocortisone—AR—cardiovascular system—obesity	0.00113	0.0367	CbGeAlD
Fludrocortisone—Insomnia—Methamphetamine—obesity	0.00113	0.00871	CcSEcCtD
Fludrocortisone—Contusion—Bupropion—obesity	0.00111	0.00857	CcSEcCtD
Fludrocortisone—Amenorrhoea—Bupropion—obesity	0.0011	0.00851	CcSEcCtD
Fludrocortisone—Insomnia—Benzphetamine—obesity	0.00109	0.0084	CcSEcCtD
Fludrocortisone—NR3C1—respiratory system—obesity	0.00107	0.0347	CbGeAlD
Fludrocortisone—Hyperhidrosis—Phendimetrazine—obesity	0.00106	0.00818	CcSEcCtD
Fludrocortisone—Fluid retention—Sibutramine—obesity	0.00105	0.00814	CcSEcCtD
Fludrocortisone—NR3C2—endocrine gland—obesity	0.00104	0.034	CbGeAlD
Fludrocortisone—Neoplasm—Orlistat—obesity	0.00104	0.00801	CcSEcCtD
Fludrocortisone—Oesophagitis—Sibutramine—obesity	0.00101	0.00783	CcSEcCtD
Fludrocortisone—Ecchymosis—Sibutramine—obesity	0.001	0.00775	CcSEcCtD
Fludrocortisone—Neoplasm—Sibutramine—obesity	0.001	0.00775	CcSEcCtD
Fludrocortisone—AR—pituitary gland—obesity	0.000998	0.0325	CbGeAlD
Fludrocortisone—AR—adipose tissue—obesity	0.000994	0.0324	CbGeAlD
Fludrocortisone—Insomnia—Phendimetrazine—obesity	0.00099	0.00765	CcSEcCtD
Fludrocortisone—Urticaria—Methamphetamine—obesity	0.000989	0.00765	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Orlistat—obesity	0.000956	0.00739	CcSEcCtD
Fludrocortisone—Urticaria—Benzphetamine—obesity	0.000954	0.00737	CcSEcCtD
Fludrocortisone—Erythema—Diethylpropion—obesity	0.000954	0.00737	CcSEcCtD
Fludrocortisone—Hypertension—Phentermine—obesity	0.000946	0.00732	CcSEcCtD
Fludrocortisone—NR3C2—liver—obesity	0.000941	0.0306	CbGeAlD
Fludrocortisone—AR—digestive system—obesity	0.000936	0.0305	CbGeAlD
Fludrocortisone—Diabetes mellitus—Sibutramine—obesity	0.000926	0.00715	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methamphetamine—obesity	0.000918	0.00709	CcSEcCtD
Fludrocortisone—Vascular purpura—Sibutramine—obesity	0.0009	0.00696	CcSEcCtD
Fludrocortisone—Oedema—Phentermine—obesity	0.000895	0.00692	CcSEcCtD
Fludrocortisone—NR3C1—adrenal cortex—obesity	0.000895	0.0291	CbGeAlD
Fludrocortisone—AR—adrenal gland—obesity	0.000892	0.029	CbGeAlD
Fludrocortisone—Cardiac failure congestive—Sibutramine—obesity	0.000888	0.00686	CcSEcCtD
Fludrocortisone—Hypersensitivity—Benzphetamine—obesity	0.000885	0.00684	CcSEcCtD
Fludrocortisone—Oesophagitis—Bupropion—obesity	0.000884	0.00683	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Bupropion—obesity	0.000879	0.00679	CcSEcCtD
Fludrocortisone—Injury—Sibutramine—obesity	0.000876	0.00677	CcSEcCtD
Fludrocortisone—Neoplasm—Bupropion—obesity	0.000874	0.00676	CcSEcCtD
Fludrocortisone—Ecchymosis—Bupropion—obesity	0.000874	0.00676	CcSEcCtD
Fludrocortisone—Insomnia—Phenylpropanolamine—obesity	0.000846	0.00654	CcSEcCtD
Fludrocortisone—Purpura—Sibutramine—obesity	0.000835	0.00646	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Topiramate—obesity	0.000832	0.00643	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Sibutramine—obesity	0.000832	0.00643	CcSEcCtD
Fludrocortisone—Convulsion—Diethylpropion—obesity	0.000826	0.00639	CcSEcCtD
Fludrocortisone—Glaucoma—Topiramate—obesity	0.000818	0.00632	CcSEcCtD
Fludrocortisone—NR3C1—cardiovascular system—obesity	0.000816	0.0266	CbGeAlD
Fludrocortisone—Myalgia—Diethylpropion—obesity	0.000812	0.00628	CcSEcCtD
Fludrocortisone—Insomnia—Phentermine—obesity	0.000809	0.00626	CcSEcCtD
Fludrocortisone—Affect lability—Sibutramine—obesity	0.000792	0.00613	CcSEcCtD
Fludrocortisone—Headache—Methamphetamine—obesity	0.00078	0.00603	CcSEcCtD
Fludrocortisone—AR—endocrine gland—obesity	0.000773	0.0252	CbGeAlD
Fludrocortisone—Myalgia—Cimetidine—obesity	0.000773	0.00597	CcSEcCtD
Fludrocortisone—Injury—Bupropion—obesity	0.000764	0.0059	CcSEcCtD
Fludrocortisone—Mood swings—Sibutramine—obesity	0.000763	0.0059	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Diethylpropion—obesity	0.000752	0.00582	CcSEcCtD
Fludrocortisone—Headache—Benzphetamine—obesity	0.000752	0.00582	CcSEcCtD
Fludrocortisone—Prednisone—HSD11B1—obesity	0.000752	0.0969	CrCbGaD
Fludrocortisone—Anaphylactic shock—Cimetidine—obesity	0.000741	0.00572	CcSEcCtD
Fludrocortisone—Abdominal distension—Orlistat—obesity	0.000724	0.0056	CcSEcCtD
Fludrocortisone—NR3C1—pituitary gland—obesity	0.000723	0.0235	CbGeAlD
Fludrocortisone—NR3C1—adipose tissue—obesity	0.00072	0.0234	CbGeAlD
Fludrocortisone—Urticaria—Phentermine—obesity	0.000711	0.00549	CcSEcCtD
Fludrocortisone—Muscular weakness—Sibutramine—obesity	0.00071	0.00549	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Diethylpropion—obesity	0.000709	0.00548	CcSEcCtD
Fludrocortisone—Pancreatitis—Orlistat—obesity	0.000705	0.00545	CcSEcCtD
Fludrocortisone—Insomnia—Diethylpropion—obesity	0.000704	0.00544	CcSEcCtD
Fludrocortisone—Amenorrhoea—Topiramate—obesity	0.000701	0.00542	CcSEcCtD
Fludrocortisone—Abdominal distension—Sibutramine—obesity	0.000701	0.00541	CcSEcCtD
Fludrocortisone—Sweating increased—Orlistat—obesity	0.0007	0.00541	CcSEcCtD
Fludrocortisone—AR—liver—obesity	0.000697	0.0227	CbGeAlD
Fludrocortisone—Affect lability—Bupropion—obesity	0.000691	0.00534	CcSEcCtD
Fludrocortisone—Hypersensitivity—Phenylpropanolamine—obesity	0.000689	0.00532	CcSEcCtD
Fludrocortisone—Headache—Phendimetrazine—obesity	0.000686	0.0053	CcSEcCtD
Fludrocortisone—NR3C1—digestive system—obesity	0.000678	0.0221	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Cimetidine—obesity	0.000675	0.00522	CcSEcCtD
Fludrocortisone—Mood swings—Bupropion—obesity	0.000665	0.00514	CcSEcCtD
Fludrocortisone—NR3C1—adrenal gland—obesity	0.000646	0.021	CbGeAlD
Fludrocortisone—Asthenia—Phentermine—obesity	0.000642	0.00496	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Sibutramine—obesity	0.000628	0.00485	CcSEcCtD
Fludrocortisone—Muscular weakness—Bupropion—obesity	0.000619	0.00479	CcSEcCtD
Fludrocortisone—Urticaria—Diethylpropion—obesity	0.000618	0.00478	CcSEcCtD
Fludrocortisone—Abdominal distension—Bupropion—obesity	0.000611	0.00472	CcSEcCtD
Fludrocortisone—Pancreatitis—Bupropion—obesity	0.000595	0.0046	CcSEcCtD
Fludrocortisone—Sweating increased—Bupropion—obesity	0.000591	0.00457	CcSEcCtD
Fludrocortisone—Fluid retention—Topiramate—obesity	0.000585	0.00452	CcSEcCtD
Fludrocortisone—Haemoglobin—Orlistat—obesity	0.000578	0.00447	CcSEcCtD
Fludrocortisone—Haemorrhage—Orlistat—obesity	0.000576	0.00445	CcSEcCtD
Fludrocortisone—Oesophagitis—Topiramate—obesity	0.000563	0.00435	CcSEcCtD
Fludrocortisone—Headache—Phentermine—obesity	0.000561	0.00433	CcSEcCtD
Fludrocortisone—NR3C1—endocrine gland—obesity	0.00056	0.0182	CbGeAlD
Fludrocortisone—Rash maculo-papular—Topiramate—obesity	0.00056	0.00433	CcSEcCtD
Fludrocortisone—Haemoglobin—Sibutramine—obesity	0.00056	0.00433	CcSEcCtD
Fludrocortisone—Haemorrhage—Sibutramine—obesity	0.000557	0.00431	CcSEcCtD
Fludrocortisone—Neoplasm—Topiramate—obesity	0.000557	0.00431	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Bupropion—obesity	0.000547	0.00423	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cimetidine—obesity	0.000546	0.00422	CcSEcCtD
Fludrocortisone—Asthenia—Cimetidine—obesity	0.000531	0.00411	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Topiramate—obesity	0.000514	0.00397	CcSEcCtD
Fludrocortisone—NR3C1—liver—obesity	0.000505	0.0164	CbGeAlD
Fludrocortisone—Vascular purpura—Topiramate—obesity	0.0005	0.00386	CcSEcCtD
Fludrocortisone—Haemoglobin—Bupropion—obesity	0.000488	0.00377	CcSEcCtD
Fludrocortisone—Headache—Diethylpropion—obesity	0.000488	0.00377	CcSEcCtD
Fludrocortisone—Haemorrhage—Bupropion—obesity	0.000486	0.00375	CcSEcCtD
Fludrocortisone—Headache—Cimetidine—obesity	0.000464	0.00359	CcSEcCtD
Fludrocortisone—Purpura—Topiramate—obesity	0.000464	0.00359	CcSEcCtD
Fludrocortisone—Vertigo—Orlistat—obesity	0.00045	0.00348	CcSEcCtD
Fludrocortisone—Affect lability—Topiramate—obesity	0.00044	0.0034	CcSEcCtD
Fludrocortisone—Vertigo—Sibutramine—obesity	0.000436	0.00337	CcSEcCtD
Fludrocortisone—Convulsion—Orlistat—obesity	0.000434	0.00336	CcSEcCtD
Fludrocortisone—Myalgia—Orlistat—obesity	0.000427	0.0033	CcSEcCtD
Fludrocortisone—Mood swings—Topiramate—obesity	0.000424	0.00327	CcSEcCtD
Fludrocortisone—Convulsion—Sibutramine—obesity	0.00042	0.00325	CcSEcCtD
Fludrocortisone—Hypertension—Sibutramine—obesity	0.000419	0.00324	CcSEcCtD
Fludrocortisone—Myalgia—Sibutramine—obesity	0.000413	0.00319	CcSEcCtD
Fludrocortisone—Oedema—Orlistat—obesity	0.000409	0.00316	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Orlistat—obesity	0.000409	0.00316	CcSEcCtD
Fludrocortisone—Infection—Orlistat—obesity	0.000406	0.00314	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Sibutramine—obesity	0.000396	0.00306	CcSEcCtD
Fludrocortisone—Oedema—Sibutramine—obesity	0.000396	0.00306	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Orlistat—obesity	0.000395	0.00306	CcSEcCtD
Fludrocortisone—Muscular weakness—Topiramate—obesity	0.000394	0.00305	CcSEcCtD
Fludrocortisone—Infection—Sibutramine—obesity	0.000393	0.00304	CcSEcCtD
Fludrocortisone—Abdominal distension—Topiramate—obesity	0.000389	0.00301	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Sibutramine—obesity	0.000383	0.00296	CcSEcCtD
Fludrocortisone—Vertigo—Bupropion—obesity	0.00038	0.00294	CcSEcCtD
Fludrocortisone—Pancreatitis—Topiramate—obesity	0.000379	0.00293	CcSEcCtD
Fludrocortisone—Sweating increased—Topiramate—obesity	0.000376	0.00291	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Orlistat—obesity	0.000373	0.00288	CcSEcCtD
Fludrocortisone—Insomnia—Orlistat—obesity	0.00037	0.00286	CcSEcCtD
Fludrocortisone—Convulsion—Bupropion—obesity	0.000366	0.00283	CcSEcCtD
Fludrocortisone—Hypertension—Bupropion—obesity	0.000365	0.00282	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Sibutramine—obesity	0.000361	0.00279	CcSEcCtD
Fludrocortisone—Myalgia—Bupropion—obesity	0.00036	0.00278	CcSEcCtD
Fludrocortisone—Insomnia—Sibutramine—obesity	0.000358	0.00277	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Topiramate—obesity	0.000349	0.00269	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Bupropion—obesity	0.000345	0.00267	CcSEcCtD
Fludrocortisone—Oedema—Bupropion—obesity	0.000345	0.00267	CcSEcCtD
Fludrocortisone—Infection—Bupropion—obesity	0.000343	0.00265	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Bupropion—obesity	0.000333	0.00258	CcSEcCtD
Fludrocortisone—Urticaria—Orlistat—obesity	0.000325	0.00251	CcSEcCtD
Fludrocortisone—Urticaria—Sibutramine—obesity	0.000314	0.00243	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Bupropion—obesity	0.000314	0.00243	CcSEcCtD
Fludrocortisone—Medroxyprogesterone Acetate—AKR1C3—obesity	0.000314	0.0405	CrCbGaD
Fludrocortisone—Insomnia—Bupropion—obesity	0.000312	0.00241	CcSEcCtD
Fludrocortisone—Haemoglobin—Topiramate—obesity	0.000311	0.0024	CcSEcCtD
Fludrocortisone—Haemorrhage—Topiramate—obesity	0.000309	0.00239	CcSEcCtD
Fludrocortisone—Hypersensitivity—Orlistat—obesity	0.000301	0.00233	CcSEcCtD
Fludrocortisone—Asthenia—Orlistat—obesity	0.000293	0.00227	CcSEcCtD
Fludrocortisone—Hypersensitivity—Sibutramine—obesity	0.000292	0.00225	CcSEcCtD
Fludrocortisone—Asthenia—Sibutramine—obesity	0.000284	0.00219	CcSEcCtD
Fludrocortisone—Urticaria—Bupropion—obesity	0.000274	0.00212	CcSEcCtD
Fludrocortisone—Erythema—Topiramate—obesity	0.000269	0.00208	CcSEcCtD
Fludrocortisone—Headache—Orlistat—obesity	0.000256	0.00198	CcSEcCtD
Fludrocortisone—Hypersensitivity—Bupropion—obesity	0.000254	0.00196	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SIRT1—obesity	0.000252	0.0025	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—NCOA1—obesity	0.000251	0.00249	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—obesity	0.000248	0.00246	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—obesity	0.000248	0.00246	CbGpPWpGaD
Fludrocortisone—Headache—Sibutramine—obesity	0.000248	0.00192	CcSEcCtD
Fludrocortisone—Asthenia—Bupropion—obesity	0.000248	0.00191	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TCF7L2—obesity	0.000246	0.00245	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CTNNBL1—obesity	0.000244	0.00243	CbGpPWpGaD
Fludrocortisone—Vertigo—Topiramate—obesity	0.000242	0.00187	CcSEcCtD
Fludrocortisone—Testosterone Propionate—COMT—obesity	0.000241	0.0311	CrCbGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—FOXO1—obesity	0.000236	0.00234	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—obesity	0.000236	0.00234	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000235	0.00233	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—obesity	0.000235	0.00233	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPIN1—obesity	0.000234	0.00232	CbGpPWpGaD
Fludrocortisone—Convulsion—Topiramate—obesity	0.000233	0.0018	CcSEcCtD
Fludrocortisone—Hypertension—Topiramate—obesity	0.000232	0.0018	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.00023	0.00228	CbGpPWpGaD
Fludrocortisone—Myalgia—Topiramate—obesity	0.000229	0.00177	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—obesity	0.000228	0.00227	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.000227	0.00225	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—obesity	0.000226	0.00225	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CPT1A—obesity	0.000222	0.0022	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000221	0.0022	CbGpPWpGaD
Fludrocortisone—Oedema—Topiramate—obesity	0.00022	0.0017	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—SIRT1—obesity	0.00022	0.00218	CbGpPWpGaD
Fludrocortisone—Infection—Topiramate—obesity	0.000218	0.00169	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—obesity	0.000218	0.00216	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARA—obesity	0.000216	0.00215	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GCK—obesity	0.000216	0.00215	CbGpPWpGaD
Fludrocortisone—Headache—Bupropion—obesity	0.000216	0.00167	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Topiramate—obesity	0.000212	0.00164	CcSEcCtD
Fludrocortisone—Diflorasone—NR3C1—obesity	0.000212	0.0274	CrCbGaD
Fludrocortisone—Desonide—NR3C1—obesity	0.000212	0.0274	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—obesity	0.00021	0.00209	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—obesity	0.000208	0.00207	CbGpPWpGaD
Fludrocortisone—Desoximetasone—NR3C1—obesity	0.000207	0.0267	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TF—obesity	0.000206	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—obesity	0.000206	0.00204	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—FOXO1—obesity	0.000205	0.00204	CbGpPWpGaD
Fludrocortisone—Loteprednol—NR3C1—obesity	0.000205	0.0264	CrCbGaD
Fludrocortisone—NR3C1—Circadian Clock—PPARA—obesity	0.000204	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—obesity	0.000204	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—PRL—obesity	0.000204	0.00202	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Topiramate—obesity	0.0002	0.00155	CcSEcCtD
Fludrocortisone—Insomnia—Topiramate—obesity	0.000199	0.00154	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—obesity	0.000197	0.00196	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—obesity	0.000197	0.00196	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—obesity	0.000196	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—obesity	0.000196	0.00194	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CST3—obesity	0.000195	0.00194	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000194	0.00193	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—obesity	0.000194	0.00192	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NAMPT—obesity	0.000191	0.0019	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—SHBG—obesity	0.00019	0.0245	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NTRK2—obesity	0.000189	0.00187	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—obesity	0.000186	0.00185	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—obesity	0.000184	0.00183	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IAPP—obesity	0.000183	0.00181	CbGpPWpGaD
Fludrocortisone—Flurandrenolide—NR3C1—obesity	0.000181	0.0234	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—obesity	0.000181	0.0018	CbGpPWpGaD
Fludrocortisone—Testosterone Propionate—AR—obesity	0.00018	0.0232	CrCbGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—obesity	0.000179	0.00177	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000178	0.00177	CbGpPWpGaD
Fludrocortisone—Hydrocortamate—NR3C1—obesity	0.000175	0.0226	CrCbGaD
Fludrocortisone—Urticaria—Topiramate—obesity	0.000175	0.00135	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000174	0.00173	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—ESR2—obesity	0.000174	0.00173	CbGpPWpGaD
Fludrocortisone—Spironolactone—SHBG—obesity	0.000174	0.0224	CrCbGaD
Fludrocortisone—Cortisone acetate—NR3C1—obesity	0.000173	0.0223	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.000172	0.00171	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CDKN2A—obesity	0.000172	0.00171	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CAV1—obesity	0.000172	0.0017	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SREBF1—obesity	0.00017	0.00169	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PIK3CA—obesity	0.00017	0.00169	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CPT1A—obesity	0.000168	0.00167	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000168	0.00167	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PARP1—obesity	0.000167	0.00166	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—AR—obesity	0.000167	0.0215	CrCbGaD
Fludrocortisone—Megestrol acetate—NR3C1—obesity	0.000166	0.0215	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GCK—obesity	0.000164	0.00163	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—SHBG—obesity	0.000163	0.021	CrCbGaD
Fludrocortisone—Amcinonide—NR3C1—obesity	0.000163	0.021	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—obesity	0.000163	0.00161	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—STK11—obesity	0.000162	0.00161	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CYP19A1—obesity	0.000162	0.00161	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Topiramate—obesity	0.000162	0.00125	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR2—obesity	0.000159	0.00157	CbGpPWpGaD
Fludrocortisone—Asthenia—Topiramate—obesity	0.000158	0.00122	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TF—obesity	0.000157	0.00155	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—ADIPOQ—obesity	0.000156	0.00155	CbGpPWpGaD
Fludrocortisone—Mometasone—NR3C1—obesity	0.000155	0.02	CrCbGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—obesity	0.000154	0.00153	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARD—obesity	0.000154	0.00153	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—SHBG—obesity	0.000153	0.0198	CrCbGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK8—obesity	0.000153	0.00152	CbGpPWpGaD
Fludrocortisone—Spironolactone—AR—obesity	0.000153	0.0197	CrCbGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—obesity	0.000152	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—obesity	0.000152	0.0015	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—obesity	0.00015	0.00149	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—APOBEC1—obesity	0.00015	0.00148	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARD—obesity	0.000149	0.00147	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR2—obesity	0.000148	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SLC2A4—obesity	0.000148	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000147	0.00146	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000147	0.00146	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NCOA1—obesity	0.000146	0.00145	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GNB3—obesity	0.000145	0.00144	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000145	0.00144	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—SIRT1—obesity	0.000144	0.00143	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—obesity	0.000143	0.00142	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—AR—obesity	0.000143	0.0184	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—BDNF—obesity	0.000141	0.0014	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—NCOA1—obesity	0.000141	0.0014	CbGpPWpGaD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—obesity	0.000141	0.0181	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—NR0B2—obesity	0.00014	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR1I3—obesity	0.00014	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—AR—obesity	0.00014	0.00139	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—obesity	0.000139	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—obesity	0.000138	0.00137	CbGpPWpGaD
Fludrocortisone—Headache—Topiramate—obesity	0.000138	0.00106	CcSEcCtD
Fludrocortisone—Clobetasol propionate—NR3C1—obesity	0.000137	0.0176	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000135	0.00134	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR0B2—obesity	0.000135	0.00134	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR1I3—obesity	0.000135	0.00134	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—AR—obesity	0.000135	0.0174	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—STK11—obesity	0.000134	0.00133	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—FOXO1—obesity	0.000134	0.00133	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—obesity	0.000134	0.00133	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—obesity	0.000134	0.00133	CbGpPWpGaD
Fludrocortisone—Triamcinolone—BCHE—obesity	0.000132	0.0171	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—ESR2—obesity	0.000132	0.00131	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—obesity	0.000132	0.00131	CbGpPWpGaD
Fludrocortisone—Fluorometholone—NR3C1—obesity	0.000132	0.017	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS1—obesity	0.000132	0.00131	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—RHOA—obesity	0.000131	0.0013	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS3—obesity	0.00013	0.00129	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PIK3R1—obesity	0.00013	0.00129	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR1I2—obesity	0.000128	0.00127	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—obesity	0.000128	0.0166	CrCbGaD
Fludrocortisone—Methylprednisolone—NR3C1—obesity	0.000127	0.0164	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARGC1A—obesity	0.000127	0.00126	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NR3C1—obesity	0.000124	0.00123	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR1I2—obesity	0.000124	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—POMC—obesity	0.000121	0.0012	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BDNF—obesity	0.00012	0.00119	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—obesity	0.000119	0.00118	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR2A—obesity	0.000119	0.00118	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—obesity	0.000117	0.00116	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—AR—obesity	0.000117	0.00116	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK8—obesity	0.000116	0.00115	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPL—obesity	0.000116	0.00115	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—SHBG—obesity	0.000116	0.0149	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—FOXO1—obesity	0.000115	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—obesity	0.000114	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—APOBEC1—obesity	0.000114	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—obesity	0.000113	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CTNNBL1—obesity	0.000113	0.00113	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR3C1—obesity	0.000113	0.00112	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—NR3C1—obesity	0.000113	0.0146	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARD—obesity	0.000113	0.00112	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—CYP19A1—obesity	0.000113	0.0145	CrCbGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000111	0.0011	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—obesity	0.00011	0.0142	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GNB3—obesity	0.00011	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.00011	0.00109	CbGpPWpGaD
Fludrocortisone—Betamethasone—CYP19A1—obesity	0.000109	0.014	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—obesity	0.000108	0.00108	CbGpPWpGaD
Fludrocortisone—Triamcinolone—NR3C1—obesity	0.000107	0.0139	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—obesity	0.000107	0.00106	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARA—obesity	0.000106	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAD—obesity	0.000106	0.00105	CbGpPWpGaD
Fludrocortisone—Spironolactone—NR3C1—obesity	0.000103	0.0133	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR0B2—obesity	0.000103	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR1I3—obesity	0.000103	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARA—obesity	0.000102	0.00102	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—obesity	0.000102	0.00101	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—IRS1—obesity	0.000101	0.00101	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—obesity	0.0001	0.000996	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS2—obesity	9.92e-05	0.000985	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—obesity	9.91e-05	0.000984	CbGpPWpGaD
Fludrocortisone—Prednisone—NR3C1—obesity	9.75e-05	0.0126	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—obesity	9.71e-05	0.000964	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—obesity	9.7e-05	0.0125	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—obesity	9.62e-05	0.000954	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—obesity	9.58e-05	0.00095	CbGpPWpGaD
Fludrocortisone—Progesterone—SHBG—obesity	9.42e-05	0.0121	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR1I2—obesity	9.39e-05	0.000931	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—obesity	9.37e-05	0.00093	CbGpPWpGaD
Fludrocortisone—Progesterone—SLC22A1—obesity	9.29e-05	0.012	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	9.28e-05	0.000921	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—obesity	9.26e-05	0.000919	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—obesity	9.03e-05	0.000896	CbGpPWpGaD
Fludrocortisone—Prednisolone—NR3C1—obesity	8.99e-05	0.0116	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—obesity	8.98e-05	0.000891	CbGpPWpGaD
Fludrocortisone—Testosterone—SHBG—obesity	8.9e-05	0.0115	CrCbGaD
Fludrocortisone—Betamethasone—NR3C1—obesity	8.8e-05	0.0114	CrCbGaD
Fludrocortisone—Testosterone—SLC22A1—obesity	8.78e-05	0.0113	CrCbGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—obesity	8.77e-05	0.000871	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAD—obesity	8.77e-05	0.00087	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IRS1—obesity	8.66e-05	0.00086	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CTNNBL1—obesity	8.6e-05	0.000854	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—obesity	8.46e-05	0.000839	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—obesity	8.3e-05	0.000823	CbGpPWpGaD
Fludrocortisone—Progesterone—AR—obesity	8.26e-05	0.0106	CrCbGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—obesity	8.21e-05	0.000814	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—obesity	8.19e-05	0.000813	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—obesity	8.08e-05	0.000802	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—obesity	8.07e-05	0.000801	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PARP1—obesity	8.06e-05	0.0008	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—obesity	8.02e-05	0.000796	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—obesity	7.96e-05	0.00079	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—obesity	7.91e-05	0.000785	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—obesity	7.9e-05	0.000784	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—obesity	7.89e-05	0.000783	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—obesity	7.85e-05	0.000779	CbGpPWpGaD
Fludrocortisone—Testosterone—AR—obesity	7.8e-05	0.0101	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—obesity	7.77e-05	0.000772	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PARP1—obesity	7.77e-05	0.000771	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR2—obesity	7.63e-05	0.000758	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—obesity	7.62e-05	0.000756	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR2—obesity	7.36e-05	0.00073	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARD—obesity	7.15e-05	0.00071	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—obesity	7.05e-05	0.0007	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	7.04e-05	0.000699	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOA1—obesity	7.03e-05	0.000698	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—NR3C1—obesity	6.87e-05	0.00886	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—obesity	6.79e-05	0.000673	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NCOA1—obesity	6.78e-05	0.000673	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AR—obesity	6.74e-05	0.000669	CbGpPWpGaD
Fludrocortisone—Testosterone—CYP19A1—obesity	6.53e-05	0.00842	CrCbGaD
Fludrocortisone—AR—Gene Expression—NR1I3—obesity	6.51e-05	0.000646	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR0B2—obesity	6.51e-05	0.000646	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	6.45e-05	0.00064	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	6.44e-05	0.000639	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—obesity	6.36e-05	0.0082	CrCbGaD
Fludrocortisone—Dexamethasone—CYP19A1—obesity	6.32e-05	0.00815	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—SIRT1—obesity	6.15e-05	0.00061	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—obesity	6.1e-05	0.00787	CrCbGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—obesity	5.97e-05	0.000592	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR1I2—obesity	5.96e-05	0.000591	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—obesity	5.95e-05	0.00059	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PARP1—obesity	5.89e-05	0.000585	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—obesity	5.64e-05	0.00056	CbGpPWpGaD
Fludrocortisone—Progesterone—NR3C1—obesity	5.6e-05	0.00722	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR2—obesity	5.58e-05	0.000554	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	5.5e-05	0.000546	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—obesity	5.45e-05	0.000541	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARD—obesity	5.42e-05	0.000538	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	5.35e-05	0.000531	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PRKCD—obesity	5.33e-05	0.000529	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—obesity	5.26e-05	0.000522	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	5.24e-05	0.00052	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—obesity	5.19e-05	0.000515	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOA1—obesity	5.14e-05	0.00051	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—obesity	5.12e-05	0.0066	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—obesity	5.12e-05	0.000508	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARA—obesity	5.11e-05	0.000507	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—obesity	5e-05	0.000496	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—obesity	5e-05	0.00644	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NR1I3—obesity	4.94e-05	0.00049	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NR0B2—obesity	4.94e-05	0.00049	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—AR—obesity	4.93e-05	0.000489	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—obesity	4.93e-05	0.00636	CrCbGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARA—obesity	4.93e-05	0.000489	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	4.88e-05	0.000485	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	4.83e-05	0.00048	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—obesity	4.81e-05	0.000477	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2E1—obesity	4.71e-05	0.00608	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—obesity	4.67e-05	0.000464	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	4.66e-05	0.000463	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—obesity	4.63e-05	0.000459	CbGpPWpGaD
Fludrocortisone—Methyltestosterone—ALB—obesity	4.61e-05	0.00595	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NR1I2—obesity	4.52e-05	0.000448	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—obesity	4.49e-05	0.000446	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—obesity	4.46e-05	0.000443	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—obesity	4.35e-05	0.000432	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—obesity	4.22e-05	0.000419	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—obesity	4.13e-05	0.00041	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—obesity	4.07e-05	0.000404	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	3.97e-05	0.000394	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—obesity	3.91e-05	0.000388	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	3.88e-05	0.000385	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—obesity	3.81e-05	0.000378	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PARP1—obesity	3.74e-05	0.000371	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARA—obesity	3.74e-05	0.000371	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—obesity	3.67e-05	0.000364	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—obesity	3.62e-05	0.00036	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR2—obesity	3.54e-05	0.000352	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—obesity	3.39e-05	0.000336	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOA1—obesity	3.26e-05	0.000324	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—obesity	3.24e-05	0.000322	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	3.13e-05	0.000311	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—obesity	3.09e-05	0.000306	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—obesity	2.91e-05	0.00375	CrCbGaD
Fludrocortisone—AR—Gene Expression—SIRT1—obesity	2.85e-05	0.000283	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PARP1—obesity	2.84e-05	0.000282	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	2.78e-05	0.000276	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR2—obesity	2.69e-05	0.000267	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—obesity	2.68e-05	0.00345	CrCbGaD
Fludrocortisone—AR—Gene Expression—NR3C1—obesity	2.53e-05	0.000251	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOA1—obesity	2.48e-05	0.000246	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PRKCD—obesity	2.47e-05	0.000245	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—obesity	2.41e-05	0.000239	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AR—obesity	2.37e-05	0.000236	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARA—obesity	2.37e-05	0.000235	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—obesity	2.32e-05	0.00023	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SIRT1—obesity	2.16e-05	0.000215	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—obesity	2.15e-05	0.000213	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—obesity	1.96e-05	0.000195	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PRKCD—obesity	1.88e-05	0.000186	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARA—obesity	1.8e-05	0.000179	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—obesity	1.77e-05	0.000175	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—obesity	1.76e-05	0.000175	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—obesity	1.67e-05	0.000166	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—obesity	1.63e-05	0.000162	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—obesity	1.49e-05	0.000148	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—obesity	1.34e-05	0.000133	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—obesity	1.12e-05	0.000111	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—obesity	8.48e-06	8.41e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—obesity	7.75e-06	7.69e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—obesity	5.88e-06	5.83e-05	CbGpPWpGaD
